Bridgemedica today announced that RELiZORB has been selected as the Gold Winner in the Over-the-Counter and Self-Care category of the 18th Annual Medical Design Excellence Awards competition. The 2016 MDEA winning products were announced at the 2016 MDEA Ceremony held Tuesday, June 14, 2016 in conjunction with the MD&M East event at the Jacob K. Javits Convention Center in New York.
RELiZORB is a digestive enzyme cartridge designed to mimic the function of pancreatic lipase by hydrolyzing fats in enteral tube feed formula just prior to ingestion in order to increase absorbable calories and reduce fatty acid deficiencies of critical fats.
"We are honored to be recognized by the MDEA judges for the design of this innovative product," said Bob Pelletier, President of Bridgemedica. "and proud to be a true partner to our client Alcresta Therapeutics"
The MDEA are the medtech industry's premier design competition committed to searching worldwide for the highest caliber finished medical devices, products, systems, or packaging available on the market. The awards program celebrates the achievements of the medical device manufacturers, their suppliers, and the many people behind the scenes-engineers, scientists, designers, and clinicians-who are responsible for the cutting-edge products that are saving lives; improving patient healthcare; and transforming medtech-one innovation at a time. For more information about the Medical Design Excellence Awards visit the MDEA website at www.MDEAwards.com.
Bridgemedica is a turnkey concept-to-supply partner providing a single source solution to medical device and biotech companies lacking engineering resources, technical expertise or operational infrastructure to move their new product ideas or project(s) to completion rapidly.
Service offerings includes industrial design, product design, product & process development, packaging design, sourcing, assembly/manufacturing, and packaging services emphasizing critical milestone realization, speed to market and earlier product revenue generation. In addition, Bridgemedica offers services in the areas of design control, compliance related documentation tracking, and regulatory filings. Bridgemedica also has the unique capability of developing and assembling Combination Products which brings together a medical device with a Drug or Biologic.
The company is ISO 13485:2003 registered an FDA registered. Bridgemedica has 41,000 square feet of space including an ISO Class 8 Certified Cleanroom (100,000). The facility includes offices, five development labs (including mechanical, electrical, process and wet lab), a QA lab, a rapid prototyping shop including 3D printing, collaboration space, clean room assembly, electro-mechanical assembly and warehouse.
For more information visit www.bridgemedica.com or call 508.406.2100